Biotech · Private company
Bellerophon Pulse Technologies
Track this companyFree. Adds Bellerophon Pulse Technologies to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Inhaled Nitric OxidePhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled Nitric Oxide 75 mcg/kg IBW/hrPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- iNOPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- INOpulsePhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- INOpulse®Phase 3 · Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Open Label ExtensionPhase 3 · Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled Nitric Oxide 0.025 mg/kg IBW/hr delivered via INOpulse DS DevicePhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled nitric oxide 0.075 mg/kg IBW/hr delivered via INOpulse DS DevicePhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled NO delivered via INOpulse DS-C DevicePhase 2 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary HypertensionPHASE3 · TERMINATED · started Dec 14, 2020ClinicalTrials.gov NCT03267108 · fetched Nov 12, 2026
- A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19PHASE3 · TERMINATED · started Jul 12, 2020ClinicalTrials.gov NCT04421508 · fetched Nov 12, 2026
- Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled NitricPHASE3 · WITHDRAWN · started Aug 1, 2018ClinicalTrials.gov NCT03602781 · fetched Nov 12, 2026
- Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHPHASE3 · TERMINATED · started Apr 1, 2016ClinicalTrials.gov NCT02725372 · fetched Nov 12, 2026
- Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAHPHASE3 · UNKNOWN · started Mar 1, 2016ClinicalTrials.gov NCT02652429 · fetched Nov 12, 2026
- Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPDPHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01728220 · fetched Nov 12, 2026
- Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)PHASE2 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01457781 · fetched Nov 12, 2026